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On December 5, 2014, the Immune Risk SRP, participants from the JSC, HQ, the NSBRI, and 
NRESS participated in a WebEx/teleconference.  The purpose of the call (as stated in the 
Statement of Task) was to allow the SRP members to: 
 
1. Receive an update by the Human Research Program (HRP) Chief Scientist or Deputy 
Chief Scientist on the status of NASA’s current and future exploration plans and the 
impact these will have on the HRP. 
2. Receive an update on any changes within the HRP since the 2013 SRP meeting. 
3. Receive an update by the Element or Project Scientist(s) on progress since the 2013 SRP 
meeting. 
4. Participate in a discussion with the HRP Chief Scientist, Deputy Chief Scientist, and the 
Element regarding possible topics to be addressed at the next SRP meeting 
 
Based on the presentations and the discussion during the WebEx/teleconference, the SRP would 
like to relay the following information to Dr. Shelhamer, the HRP Chief Scientist. 
 
Even though the SRP just had a site visit review with the immune portfolio in February 2014, the 
SRP is pleased with the progress and program development since then. Dr. Crucian and his team 
are to be commended for their strong work and innovative future plans. 
 
The SRP thinks that going forward, Dr. Crucian and other investigators must duplicate blood 
drawing/processing conditions in their ground–based models with those associated with 
astronaut samples obtained during flight – or at the very least present compelling data to show 
the equivalency of various collection/processing methodologies.  This will be especially 
important going forward as methodologies for in–flight sampling change.  The natural tendency 
will be to do direct data comparisons of astronaut and/or ground-based controls using different 
collection methodologies.  This must be demonstrated with direct comparisons of the different 
collection methods using the same assays in the same labs. 
 
